Genetic Aspects of Development*:
|
|
- Jonathan Gordon
- 6 years ago
- Views:
Transcription
1 Genetic Aspects of Development*: Vascular Anomalies & Overgrowth Syndromes Pascal BROUILLARD, PhD Human Molecular Gene:cs de Duve Ins:tute, Université catholique de Louvain Brussels, BELGIUM * Thompson & Thompson: Genetics in Medicine, 7th ed., chapter 14 1 Vasculogenesis and Angiogenesis mesoderm primary capillary plexus maturation artery bfgf, Vegf A, Nrp 1,2 blood islands Vegf A- Vegfr1,Vegfr2 remodeling capillaries vein Hematopoietic Precursors: Blood Cells Vegf A-Vegfr2, Tgfb1, TgfbR2 Hemangioblasts: Vascular Endothelial Cells Vascular smooth muscle cells Tie2-Angpt 1,2, Vegfr3- Vegfc, Ephrins-Ephs, CoupTFII, Rasa1, Shp2, VE- Cadherin 2 1
2 Vascular Anomalies Diagnosis: clinical history, examination & tests 3 Vascular Anomalies: characteristics Large clinical variability Commonly sporadic; rare familial forms Localized lesions: Single (sporadic) or multiple (familial) Pure forms versus associations & syndromes 4 2
3 Classification of Vascular Anomalies Tumors Malformations Hemangioma Infantile hemangioma (IH) Non-involuting congenital hemangioma (NICH) Rapidly-involuting congenital hemangioma (RICH) Hemangioendothelioma Angiosarcoma Lymphangiosarcoma Mulliken JB and Glowacki, Plast Reconstr Surg 1982; Wassef et al, Pediatrics Classification of Vascular Anomalies Tumors Malformations Capillary CCM CM-AVM Lymphatic LE LM Venous GVM VMCM VM Arterial CM-AVM HHT Mulliken JB and Glowacki, Plast Reconstr Surg 1982; Wassef et al, Pediatrics 2015 Combined: AVM, CVM, CLVM, LVM, CLAVM (Overgrowth) syndromes: Maffucci, KTS, PWS, MLCRD. 6 3
4 Genetic bases of vascular anomalies Predisposing susceptibility genes (vs. causative) Multigenic (vs. monogenic) Polymorphism (vs. mutation) Locus heterogeneity One phenotype, many causes Inherited with reduced penetrance vs. somatic changes Mosaicism/ tissue heterogeneity Clinical phenotypic variability One gene, several clinical presentations Spatio-temporal distribution of mutations/stochastic effect 7 Genetic bases of vascular anomalies Predisposing susceptibility genes (vs. causative): IH Multigenic (vs. monogenic) Polymorphism (vs. mutation) Locus heterogeneity One phenotype, many causes Inherited with reduced penetrance vs. somatic changes Mosaicism/ tissue heterogeneity Clinical/phenotypic variability One gene, several clinical presentations Spatio-temporal distribution of mutations/stochastic effect 8 4
5 Vascular Tumors: Infantile Hemangioma PROLIFERATING Clonal ECs years INVOLUTING INVOLUTED Fibro-fatty matrix 9 Infantile Hemangioma Cells VEGF-dependent increased VEGFR2 phosphorylation Chronic activation of VEGF signaling > Phosphorylation AKT, ERK1/2, RASA1, STAT4. > Transcription VEGF, GLUT1 Hemangioma cells > Hem EC behavior Proliferation Jinnin et al, Nat Med
6 Hemangioma Etiopathogenesis Screening of 24 candidate genes: regulate EC migration/proliferation/adhesion/hif1α Control One TEM8 mutation Control Two VEGFR2 mutations 0/ 110 hemangioma patients, 0/295 controls 10/ 105 hemangioma patients, 12/295 controls Jinnin et al, Nat Med Hemangioma Etiopathogenesis VEGFR1 VEGFR1 R2=VEGFR2 β1= β1 integrin Jinnin et al, Nat Med 2008! All Hem ECs showed pathway dysregulation: Changes not necessary! Associated SNP also present in controls: Changes not sufficient! Particular combinations of predisposing germline changes cause disease 12 6
7 Genetic bases of vascular anomalies Predisposing susceptibility genes (vs. causative): IH Multigenic (vs. monogenic) Polymorphism (vs. mutation) Locus heterogeneity: CCM, PLE One phenotype, many causes Inherited with reduced penetrance vs. somatic changes Mosaicism/ tissue heterogeneity Clinical/phenotypic variability One gene, several clinical presentations Spatio-temporal distribution of mutations/stochastic effect 13 Cerebral Cavernous Malformation (CCM) Incidence: % Single or multiple lesions Epilepsy, headache, haemorrhage; Asymptomatic: 15-20% Autosomal dominant inheritance (>80%) Variable expressivity EPI 14 7
8 Genetic basis of CCM CCM2 20%, penetrance 100% CCM3 40%, penetrance 63% CCM1 40%, penetrance 88% X Y Dubovsky et al., Hum Mol Genet, 1995; Craig et al., Hum Mol Genet, Pathophysiology of CCM fibronectin cell spreading ERK1/2 α v ß1 NOTCH integrin ICAP1α PI3K/AKT CCM1 HEG1 RAP1 CCM3 membrane MEKK3 CCM2 RHOA SMURF1 hyperosmotic shock MKK3 RAC1 p38mapk ROCK proliferation apoptosis actin stress fiber formation microtubule (cell morphology) apoptosis? osmoregulation ICAP1α KRIT1? cell proliferation? nucleus CCM1: KRIT1, CCM2: malcavernin/mgc4607, CCM3: PDCD10 Adapted from Revencu et al, J Med Genet
9 Primary lymphedema Chronic accumulation of lymph within tissues Predisposition to infections Important dysfunction of extremities abnormal development and/or function of lymphatic vessels genetic predisposition 17 Primary Lymphedema: Highly heterogeneous (28 genes explain only ~30% of cases) LEC PIEZO1 HGF c-met c-met SHP2 KIF11 ADAMTS3 CCBE1 PTPN14 VEGF-C VEGFR3 VEGFR3 FAT4 CELSR1 EPHB4 CX43 CX47 (GJA1) (GJA2) ITGA9? RELN RASGAP SOS1 PI3K PTEN RAS AKT SHP2 = PTPN11 RAS = KRAS,RIT1 RASGAP = RASA1 RAF1 TSC1 TSC2 IKBKG MEK RHEB NF-κB MAPK mtor Proliferation Survival GATA2 FOXC2 FOXC2 LEC and valves Nucleus NF-κB GATA2 FOXC2 SOX18 PROX1 PROX1 ITGA9 ETS NF-κB PROX1 FLT4 Adapted from Brouillard et al, J Clin Invest 2014; Brouillard et al, Hum Mol Genet
10 Genetic bases of vascular anomalies Predisposing susceptibility genes (vs. causative): IH Multigenic (vs. monogenic) Polymorphism (vs. mutation) Locus heterogeneity: CCM, LE One phenotype, many causes Inherited with reduced penetrance vs. somatic changes: GVM, VM Mosaicism/ tissue heterogeneity Clinical/phenotypic variability One gene, several clinical presentations Spatio-temporal distribution of mutations/stochastic effect 19 Glomuvenous Malformation (GVM)! 5% of venous anomalies! Caused by loss-of-function mutations in glomulin! Autosomal dominant, with reduced penetrance & phenotypic heterogeneity! Does lesion-formation require an additional somatic event? Boon et al, Hum Mol Genet
11 First somatic 2 nd hit identified in a vascular malformation Inherited: (IVS7-2884)-(IVS13+255) del 8.4 kb+insgg E8- E13 Ad- 1 Ad- 3 Ad- 4 * * Ad- 12 Ad- 11 Somatic: 980delCAGAA (E10) Brouillard et al. Am. J Hum Genet Complete local loss of glomulin wt 2 nd somatic mutation inherited mutation inherited mutation SMC α ac:n 22 11
12 Local loss of wild-type glomulin expression: genomic deletion? Affymetrix SNP arrays on lesion-dna Chromosome 1 Affymetrix 250K (NspI) GVM71_12 1pter 1p qter Copy number (1 SNP) c.107insg GLMN Average copy number (10 SNPs) Cytoband Heterozygous SNPs Cen Amyere et al, Am J Hum Genet Somatic 2 nd hits in GVM Pairwise comparison of allele-specific copy number Blood DNA Allele A Blood Allele B Blood Pairwise analysis Allele A Blood Allele A GVM GVM lesion DNA Allele A GVM Allele B GVM Allele B Blood Allele B GVM Amyere et al, Am J Hum Genet
13 Somatic 2 nd hits in GVM GVM22 Chromosome 1 Copy number (1 SNP) Average copy number (10X SNPs) Cytoband Heterozygous SNPs Discrepancy calls Pairwise CN c.157delaagaa 1pter 1qter LOH Loss of WT allele expression in GVM tissue Cen Similar observation in 12 GVM lesions Amyere et al, Am J Hum Genet aupid: A novel mechanism for glomulin loss Allelic imbalance (LOH) without copy number change in tissue: acquired Uniparental Isodisomy 1p aupid detected in 9/25 GVM tissues, not present in 54 control pairwise comparisons Amyere et al, Am J Hum Genet
14 Autosomal dominant with incomplete penetrance: recessive at the level of the cell! Glomuvenous malformation Cutaneomucosal Venous Malformation (VMCM) Cerebral Cavernous Malformation (CCM) 27 Venous Malformations: mostly sporadic Enlarged venous channels Single EC layer, with patchy vsmc Typically sporadic (>98%) Familial forms caused by TIE2/TEK mutations 28 14
15 Sporadic VM: Tissue heterogeneity hides mutation Sanger sequencing: cumulative signal 40% mutant <allele 10% mutant allele 5% mutant allele 29 Overcoming tissue heterogeneity: cdna-based screens DNA VM Tissue WT Mutant = cdna = abnormal EC = normal EC = other cells - DNA screens: TIE2 gene present in all cell types - cdna screens: TIE2 expression primarily from ECs (Semi quantitative minisequencing): SNaPshot Limaye et al., Nat Genet
16 Overcoming tissue heterogeneity: Deep (Next Generation) Sequencing 9 mut (T): 170 wt (C) " Should include negatives to distinguish low-freq alleles from background/noise! 31 Somatic TIE2/TEK mutations cause >60% of VMs (1-10% of mutant alleles detected) Ig2 74% EGF Ig1 Ig3 FN III L914F Y897F R915L R849W G1115* Y897H, F, C, S L914F R915C, L S917I TK R849W R918C TK F960I R1099* T1105N T1106P E1109Lfs*5 G1115* Limaye et al, Nat Genet 2009; Soblet et al, Mol Syndromol 2013 T1105N T1106P Y897F R1099* T1105N G1115* 32 16
17 Somatic TIE2/TEK mutations cause >60% of VMs EGF Ig2 Ig3 Ig1 Hyper-phosphorylation of mutants vec WT L914F R849W vec WT Y897F+ R915L Y897F R915L p-tyr FN III TIE2 B Growth factor RTK Cell membrane Y897H, F, C, S L914F R915C, L S917I TK R849W R918C TIE2 P P PIP 2 PIP 3 p85 PIK3CA AKT TK F960I R1099* T1105N T1106P E1109Lfs*5 G1115* Cell proliferation, cell survival, transformation, cell motility, insulin response pathways Apoptosis, cell cycle, cell cycle arrest pathways Limaye et al, Nat Genet 2009; Soblet et al, Mol Syndromol 2013, Uebelhoer et al, 2013, Natynki et al, Hum Mol Genet Somatic PIK3CA mutations cause 20% of VM A B E Skin Involvement No skin Involvement 40 p < C D Number of indivuduals 20 0 p < vs. TEK p = vs. N.D. p = vs. TEK TEK PIK3CA N.D. Mutation detected VM: Venous malformation Limaye et al, Am J Hum Genet
18 Genetic bases of vascular anomalies Predisposing susceptibility genes (vs. causative): IH Multigenic (vs. monogenic) Polymorphism (vs. mutation) Locus heterogeneity: CCM, LE One phenotype, many causes Inherited with reduced penetrance vs. somatic changes: GVM, VM Mosaicism/ tissue heterogeneity Clinical/phenotypic variability: VM-LM-PROS One gene, several clinical presentations Spatio-temporal distribution of mutations/stochastic effect 35 Somatic PIK3CA mutations also cause 72% of LM (Lymphatic malformations)! No-flow malformations! Filled with lymph! Macro- or micro-cystic! Present in utero! Grow with the individual Boscolo et al, 2015; Osborne et al, 2015; Luks et al, 2015; Schlogel et al, In Prep 36 18
19 Somatic PIK3CA mutations also cause PROS (PIK3CA-Related Overgrowth Syndromes) MCAP: Megalencephaly Capillary Malformation KT: Klippel Trenaunay CLVM with overgrowth CLOVES: Congenital Lipomatous Overgrowth, Vascular malformation, Epidermal nevi, Scoliosis Macrodactyly Keppler-Noreuil et al, Am J Med Genet Somatic PIK3CA mutations cause a spectrum of phenotypes Keppler-Noreuil et al, Am J Med Genet
20 Genetic bases of vascular anomalies Predisposing susceptibility genes (vs. causative): IH Multigenic (vs. monogenic) Polymorphism (vs. mutation) Locus heterogeneity: CCM, LE One phenotype, many causes Inherited with reduced penetrance vs. somatic changes: GVM, VM Mosaicism/ tissue heterogeneity Clinical/phenotypic variability: VM-LM-PROS, CM-AVM One gene, several clinical presentations Spatio-temporal distribution of mutations/stochastic effect 39 RASA1 and EPHB4 Mutations cause CM-AVM (Capillary Malformation-Arteriovenous Malformation) RASA1 c.806deltttac c.951insg c.957g>a c.613delcttat c.1208insc ATG c g>t c.1575insatgt c g>a c.2341g>t c.2365c>t c.2422c>t c.1490t>g c.1636c>t c delg c a>g c.1683deltc c delgtta c.2125c>t c.2532deltttaa c.1277a>g c g>a c.1279c>t c inst c g>t c.3028c>t c.3052delg TAG SH2 SH3 SH2 PH C2 Ras-GAP c.1336c>t c g>a c.1619g>a c insa c.828+3a>t c.1192c>t c.1870c>t c inst c.656c>g c.1350inst c.1579delgtct c.2026c>t c.2514insa c.512delt c.1480inst c.2288a>t c.2579deltcat c.475delct c.1362instcagt c.2336delgc c.2450delct EPHB4 c.41261g>t) c.389g>a) c.123+3g>c) c.814_816delcta) c.730c>t) c g>a) c.632_633deltg) c.2215c>t) c.481_485delgtcainstt) c.447_448insgaag) c g>c) c.1558c>t) c.2037_2038inst) c.1291c>t) c.1177_1177delg) c.1788t>g) c.1123g>t) c t>g) c.1077_1081delccgct) c g>a) c.1054c>t) c g>a) c.2418c>g) c.1615delg) c.2379delc) c.33delg) c.1733_1734insa) c.221g>c) c.1406t>c) c.175g>a) c.1546g>a) c.802t>c) c.560t>c) Revencu et al, Hum Mutat 2008; Amyere et al, Circulation 2017 p.e664k;)c.1990g>a) c.1966c>t) c.2173g>a) C.2233A>G) c.2366c>g) c.2365c>t) c.2458c>a) c.2459c>t) c.2419g>a) c.2621t>c) c.2590c>t;)p.r864w) c.2567g>a) c.2533t>c;)p.c845r) c.2512c>t;)r838w) 40 20
21 Phenotypic variability in CM-AVM B Eerola et al, Am J Hum Genet 2003; Revencu et al, Inborn errors of development 2nd Ed, RASA1 Phenotypes RASA1 mutations in 314 individuals from 132 families 306: multifocal CM (97%) 101: Accompanying fast-flow lesions 26 Parkes Weber syndrome (8.5%) 32 Intra-CNS AVM/AVF (10%) 43 Extra-CNS AVM/AVF (13%) Large inter- and intra-familial variability I. II. III. Revencu et al, Hum Mutat
22 Genetic bases of vascular anomalies Predisposing susceptibility genes (vs. causative): IH Multigenic (vs. monogenic) Polymorphism (vs. mutation) Locus heterogeneity: CCM, LE One phenotype, many causes Inherited with reduced penetrance vs. somatic changes: GVM, VM Mosaicism/ tissue heterogeneity Clinical/phenotypic variability: VM-LM-PROS, CM-AVM Spatio-temporal distribution of mutations/genetic background/environment/ stochastic effect Thanks for your attention! 43 22
Classification des Malformations vasculaires
Classification des Malformations vasculaires Gilles Soulez, MD, MSc, FSIR Professeur Titulaire et Chairman Dpt Radiologie, Radio-Oncologie et Medecine Nucléaire Université de Montréal Basic principles
More informationISSVA classification for vascular anomalies (Approved at the 20th ISSVA Workshop, Melbourne, April 2014, last revision May 2018)
ISSVA classification for vascular anomalies (Approved at the 20th ISSVA Workshop, Melbourne, April 2014, last revision May 2018) This classification is intended to evolve as our understanding of the biology
More informationMultifocal vascular anomalies: Common, less common, and rare
Multifocal vascular anomalies: Common, less common, and rare Ilona J. Frieden Professor of Dermatology and Pediatrics University of California, San Francisco Conflict of interests: Pierre Fabre Dermo-Cosmétique
More informationVascular Tumors in Children and Adults. Thuy Phung, MD, PhD Houston Methodist Hospital Texas Children s Hospital Baylor College of Medicine
Vascular Tumors in Children and Adults Thuy Phung, MD, PhD Houston Methodist Hospital Texas Children s Hospital Baylor College of Medicine What are these lesions? (Marcelo Hochman, MD) What are these lesions?
More informationWhat Syndrome s That? Syndromes Associated with Vascular Anomalies
What Syndrome s That? Syndromes Associated with Vascular Anomalies Dawn Siegel, MD Medical College of Wisconsin American Academy of Dermatology Meeting San Diego, CA Sat. February 17 th, 2018 Learning
More informationAngiogenesis in Human Development. Vascular Development
Angiogenesis in Human Development Jan Kitajewski ICRC 217B, ph 851-4688, email: jkk9 BACKGROUND READING: Vascular Development Signaling Vascular Morphogenesis and Maintenance Douglas Hanahan. Science 277:
More informationGenetics of lymphatic anomalies
Review series Genetics of lymphatic anomalies Pascal Brouillard, 1 Laurence Boon, 1,2 and Miikka Vikkula 1,2,3 1 Laboratory of Human Molecular Genetics, de Duve Institute, 2 Center for Vascular Anomalies,
More informationVascular Anomalies: From the Dermatologist s Perspective
Vascular Anomalies: From the Dermatologist s Perspective Aimee Smidt, MD, FAAD, FAAP University of New Mexico School of Medicine, Depts. of Dermatology & Pediatrics April 2018 No conflict of interest to
More informationClinical Perspective: Vascular Anomalies with revised 2014 ISSVA Classification
Clinical Perspective: Vascular Anomalies with revised 2014 ISSVA Classification Joao uilherme Amaral Pediatric Interventional Radiologist Division Chief Image uided Therapy Centre - The Hospital for Sick
More informationSupplementary Table e1. Clinical and genetic data on the 37 participants from the WUSM
Supplementary Data Supplementary Table e1. Clinical and genetic data on the 37 participants from the WUSM cohort. Supplementary Table e2. Specificity, sensitivity and unadjusted ORs for glioma in participants
More informationVascular malformations: localized defects in vascular morphogenesis
Clin Genet 2003: 63: 340 351 Copyright # Blackwell Munksgaard 2003 Printed in Denmark All rights reserved CLINICAL GENETICS ISSN 0009-9163 Developmental Biology: Frontiers for Clinical Genetics Section
More informationKlippel - Trenaunay Syndrome (KTS) When and What to do? Dr. Ayhan ŞENOL SBU.Gazi Yasargil ETH. Diyarbakır /TURKEY
Klippel - Trenaunay Syndrome (KTS) When and What to do? Dr. Ayhan ŞENOL SBU.Gazi Yasargil ETH. Diyarbakır /TURKEY Disclosure Speaker name: Ayhan ŞENOL I have the following potential conflicts of interest
More informationHIGH-FLOW ARTERIOVENOUS MALFORMATION WİTHİN ENLARGED FETAL LEG (Congenital Hemangioma vs Parkes Weber Syndrome)
HIGH-FLOW ARTERIOVENOUS MALFORMATION WİTHİN ENLARGED FETAL LEG (Congenital Hemangioma vs Parkes Weber Syndrome) DORUK CEVDI KATLAN, MD Department of Obstetrics and Gynecology / Perinatology Suleymaniye
More informationSingle Gene (Monogenic) Disorders. Mendelian Inheritance: Definitions. Mendelian Inheritance: Definitions
Single Gene (Monogenic) Disorders Mendelian Inheritance: Definitions A genetic locus is a specific position or location on a chromosome. Frequently, locus is used to refer to a specific gene. Alleles are
More informationTumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
More informationCHAPTER IV RESULTS Microcephaly General description
47 CHAPTER IV RESULTS 4.1. Microcephaly 4.1.1. General description This study found that from a previous study of 527 individuals with MR, 48 (23 female and 25 male) unrelated individuals were identified
More informationKRAS: ONE ACTOR, MANY POTENTIAL ROLES IN DIAGNOSIS
UNIVERSITÀ DEGLI STUDI DI PALERMO Scuola di Specializzazione in Biochimica Clinica Direttore Prof. Marcello Ciaccio KRAS: ONE ACTOR, MANY POTENTIAL ROLES IN DIAGNOSIS Loredana Bruno KRAS gene Proto-oncogene
More informationSupplementary Figure 1
Supplementary Figure 1 A B HEC1A PTEN +/+ HEC1A PTEN -/- 16 HEC1A PTEN -/- 22 PTEN RAD51 % Cells with RAD51 foci 40 -IR +IR 30 20 10 * *! TUBULIN 0 HEC1A PTEN+/+ HEC1A PTEN-/- 16 HEC1A PTEN-/- 22 C D 1.0
More informationHistopathology of Pediatric Vascular Anomalies using the International Society of Vascular Anomalies Classification - a must know for all
Histopathology of Pediatric Vascular Anomalies using the International Society of Vascular Anomalies Classification - a must know for all Anita Gupta, MD Assistant Professor in the Department of Pathology,
More informationB16F1 B16F10 Supplemental Figure S1
B16F1 B16F1 Supplemental Figure S1 Representative microangiography images of B16F1 and B16F1 tumors grown in the cranial windows. FITC-dextran (2 million MW) was injected systemically to visualize blood
More informationSonography of soft-tissue vascular lesions
Sonography of soft-tissue vascular lesions Oscar M. Navarro Associate Professor, University of Toronto Dept. of Diagnostic Imaging, The Hospital for Sick Children Toronto, Canada Declaration of Disclosure
More informationComment je réponds au clinicien qui me demande de classer (selon ISSVA) une tache de naissance?
Comment je réponds au clinicien qui me demande de classer (selon ISSVA) une tache de naissance? Ph. Clapuyt, L. Boon Cliniques universitaires saint Luc Université catholique de Louvain 1200 Bruxelles Les
More informationDevelopment of Carcinoma Pathways
The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019
More informationHST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007
MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.
More informationEarly Embryonic Development
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors 2. Receptors 3. Regulatory proteins Maternal
More informationUpdate on Vascular Malformation Overgrowth Syndromes
Update on Vascular Malformation Overgrowth Syndromes Megha M. Tollefson, MD Associate Professor of Dermatology and Pediatrics July 27, 2017 2015 MFMER slide-1 Disclosures None 2015 MFMER slide-2 Vascular
More informationInsights from Sequencing the Melanoma Exome
Insights from Sequencing the Melanoma Exome Michael Krauthammer, MD PhD, December 2 2015 Yale University School Yof Medicine 1 2012 Exome Screens and Results Exome Sequencing of 108 sun-exposed melanomas
More informationUpdate on Pediatric Vascular Tumors
Update on Pediatric Vascular Tumors Jim Treat, MD Associate Professor of Clinical Pediatrics and Dermatology No Relevant Conflicts of Interest PHOTOGRAPHY & VIDEOTAPING ARE STRICTLY PROHIBITED IN ALL EDUCATIONAL
More informationA Comprehensive Study of TP53 Mutations in Chronic Lymphocytic Leukemia: Analysis of 1,287 Diagnostic CLL Samples
A Comprehensive Study of TP53 Mutations in Chronic Lymphocytic Leukemia: Analysis of 1,287 Diagnostic CLL Samples Sona Pekova, MD., PhD. Chambon Ltd., Laboratory for molecular diagnostics, Prague, Czech
More informationClinical Spectrum and Genetic Mechanism of GLUT1-DS. Yasushi ITO (Tokyo Women s Medical University, Japan)
Clinical Spectrum and Genetic Mechanism of GLUT1-DS Yasushi ITO (Tokyo Women s Medical University, Japan) Glucose transporter type 1 (GLUT1) deficiency syndrome Mutation in the SLC2A1 / GLUT1 gene Deficiency
More informationBIOCHEMICAL AND MOLECULAR HETEROGENEITY IN CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY
BIOCHEMICAL AND MOLECULAR HETEROGENEITY IN CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY Carmen Sousa, Helena Fonseca, Hugo Rocha, Ana Marcão, Laura Vilarinho, Luísa Diogo, Sílvia Sequeira, Cristina Costa,
More informationVascular anomalies in children (Part 1): Vascular malformations
Vascular anomalies in children (Part 1): Vascular malformations Vascular anomalies are common problems in infancy and childhood. GPs need to have a good understanding about these conditions in order to
More information2/2/14 INTRODUCTION. Vascular Anomalies: An Introduction to Classification and Coordination of Care. VASCULAR ANOMALIES: History and Classification
INTRODUCTION Vascular Anomalies: An Introduction to Classification and Coordination of Care Cindy Kerr,RN,MSN,CPNP Erin Spera,RN,MSN,CPNP Mary Beth Sylvia,RN,MS,FNP-BC 1in 3 newborns has a vascular birthmark
More informationReview of relationship between vascular endothelial growth factor family & receptors and tumor angiogenesis
16 1 2004 2 hinese Bulletin of Life Sciences Vol. 16, No. 1 Feb., 2004 1004-0374 (2004) 01-0019-05 1 201203 2 200025 (vascular endothelial growth factor, ) (vascular permeability factor, VPF), -A -B -
More informationComprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS
Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions NF1 only NGS testing and copy number analysis for the NF1 gene (NF1
More informationVascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies Michel Wassef, MD a, Francine Blei, MD b, Denise Adams, MD c, Ahmad Alomari, MD d,
More informationHow genetic & biochemical alterations in brain tumors contribute to epileptogenesis
How genetic & biochemical alterations in brain tumors contribute to epileptogenesis December 2 nd, 2012 Joon H. Uhm, MD FRCPC Departments of Neurology & Oncology Mayo Clinic, Rochester, MN American Epilepsy
More informationGenetics in lymphoedema: Input into daily clinical practice
Genetics in lymphoedema: Input into daily clinical practice Tanja Planinšek Ručigaj Dermatovenereological Clinic, University Medical Centre Ljubljana, Slovenia Nb of patients primary secondary 5/29/2018
More informationHeart 3: Organogenesis, CHD, prenatal circulation
Heart 3: Organogenesis, CHD, prenatal circulation Heart development Development of vasculature Pathogenesis of CHD Prenatal circulation and its remodeling after birth David Sedmera Charles University First
More informationVascular Malformations of the Brain. William A. Cox, M.D. Forensic Pathologist/Neuropathologist. September 8, 2014
Vascular Malformations of the Brain William A. Cox, M.D. Forensic Pathologist/Neuropathologist September 8, 2014 Vascular malformations of the brain are classified into four principal groups: arteriovenous
More informationResearch Review Vascular Update: Morphogenesis, Tumors, Malformations, and Molecular Dimensions
ß 2006 Wiley-Liss, Inc. American Journal of Medical Genetics Part A 140A:2013 2038 (2006) Research Review Vascular Update: Morphogenesis, Tumors, Malformations, and Molecular Dimensions M. Michael Cohen
More informationWhole Exome Sequenced Characteristics
Supplementary Tables Supplementary Table 1: Patient characteristics of 45 whole exome sequenced HNSCC tumors Whole Exome Sequenced Characteristics Tumors (n=45) Age, years Median (range) 61.0 (19-90) Sex,
More informationGLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations q
The British Association of Plastic Surgeons (2005) 58, 348 352 GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations q J. Leon-Villapalos a, K. Wolfe b, L. Kangesu
More informationSelected Vascular Birthmarks. Ilona J Frieden M.D. University of California San Francisco
Selected Vascular Birthmarks Ilona J Frieden M.D. University of California San Francisco DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY DISCLOSURES Venthera/Biobridge: Consultant Consulting Fees Pfizer Chair
More informationNon-Mendelian inheritance
Non-Mendelian inheritance Focus on Human Disorders Peter K. Rogan, Ph.D. Laboratory of Human Molecular Genetics Children s Mercy Hospital Schools of Medicine & Computer Science and Engineering University
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationSrc-INACTIVE / Src-INACTIVE
Biology 169 -- Exam 1 February 2003 Answer each question, noting carefully the instructions for each. Repeat- Read the instructions for each question before answering!!! Be as specific as possible in each
More informationUltrasound of soft-tissue vascular anomalies
Ultrasound of soft-tissue vascular anomalies Oscar M. Navarro Associate Professor, University of Toronto Dept. of Diagnostic Imaging, The Hospital for Sick Children Toronto, Canada Declaration of Disclosure
More informationSupplementary Figure 1: Func8onal Network Analysis of Kinases Significantly Modulated by MERS CoV Infec8on and Conserved Across All Time Points
A. B. 8 4 Supplementary Figure : Func8onal Network Analysis of Kinases Significantly Modulated by MERS CoV Infec8on and Conserved Across All Time Points Examined. A) Venn diagram analysis of kinases significantly
More informationComprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS
Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions on Blood/Saliva NF1- only NGS testing and copy number analysis for
More informationCS2220 Introduction to Computational Biology
CS2220 Introduction to Computational Biology WEEK 8: GENOME-WIDE ASSOCIATION STUDIES (GWAS) 1 Dr. Mengling FENG Institute for Infocomm Research Massachusetts Institute of Technology mfeng@mit.edu PLANS
More informationTransgenic Mice and Genetargeting
Transgenic Mice and Genetargeting mice In Biomedical Science Techniques of transgenic and gene-targeting mice are indispensable for analyses of in vivo functions of particular genes and roles of their
More informationUltrasound imaging of vascular anomalies: pearls and pitfalls
Ultrasound imaging of vascular anomalies: pearls and pitfalls Oscar Navarro, MD Dept. of Medical Imaging, University of Toronto Dept. of Diagnostic Imaging, The Hospital for Sick Children Declaration of
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationPATHOBIOLOGY OF NEOPLASIA
PATHOBIOLOGY OF NEOPLASIA Department of Pathology Gadjah Mada University School of Medicine dr. Harijadi Blok Biomedis, 6 Maret 2009 [12] 3/17/2009 1 The pathobiology of neoplasia Normal cells Malignant
More informationJULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology
JULY 21, 2018 Genetics 101: SCN1A Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology Disclosures: I have no financial interests or relationships to disclose. Objectives 1. Review genetic
More informationNext generation histopathological diagnosis for precision medicine in solid cancers
Next generation histopathological diagnosis for precision medicine in solid cancers from genomics to clinical application Aldo Scarpa ARC-NET Applied Research on Cancer Department of Pathology and Diagnostics
More informationSupplementary Online Content
Supplementary Online Content Ku CA, Hull S, Arno G, et al. Detailed clinical phenotype and molecular genetic findings in CLN3-associated isolated retinal degeneration. JAMA Ophthalmol. Published online
More informationTHE HALLMARKS OF CANCER
THE HALLMARKS OF CANCER ONCOGENES - Most of the oncogenes were first identified in retroviruses: EGFR (ErbB), Src, Ras, Myc, PI3K and others (slightly more than 30) - Mutated cellular genes incorporated
More informationFamilial PAH. Genetics and pulmonary arterial hypertension. PAH and mutations in the bone morphogenetic protein type II receptor (BMPR-II)
athology of vascular lesions in idiopathic pulmonary arterial hypertension Genetics and pulmonary arterial hypertension Concentric intimal lesion Nick Morrell British Heart Foundation rofessor of Cardiopulmonary
More informationC) The graph should look exactly like the graph on the left (Mut1 cells + Mating Pheromone for 3 hours at 25 degrees). The cells arrest in G1.
706-2000-Exam 4 Answer Key 1) The question asks you to explain peaks A and B in the top graph. The other two graphs were there to give you hints. The question did not ask for these other two graphs to
More informationIntroduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.
Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)
More informationCancer. October is National Breast Cancer Awareness Month
Cancer October is National Breast Cancer Awareness Month Objectives 1: Gene regulation Explain how cells in all the different parts of your body develop such different characteristics and functions. Contrast
More informationKaryotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl
Chapt. 18 Cancer Molecular Biology of Cancer Student Learning Outcomes: Describe cancer diseases in which cells no longer respond Describe how cancers come from genomic mutations (inherited or somatic)
More informationMarcatori biomolecolari dei carcinomi del colon-retto sporadici ed ereditari
Marcatori biomolecolari dei carcinomi del colon-retto sporadici ed ereditari Milo Frattini XII Congresso AIFEG Villa Cagnola - Gazzada Schianno (VA) 16/17.10.2014 APC β-catenina APC Met (p16) Models of
More informationHuman Molecular Genetics
Human Molecular Genetics Genetic causes of vascular malformations Pascal Brouillard and Miikka Vikkula Hum. Mol. Genet. 16:140-149, 2007. First published 31 Jul 2007; doi:10.1093/hmg/ddm211 References
More informationAP VP DLP H&E. p-akt DLP
A B AP VP DLP H&E AP AP VP DLP p-akt wild-type prostate PTEN-null prostate Supplementary Fig. 1. Targeted deletion of PTEN in prostate epithelium resulted in HG-PIN in all three lobes. (A) The anatomy
More informationLinkage analysis: Prostate Cancer
Linkage analysis: Prostate Cancer Prostate Cancer It is the most frequent cancer (after nonmelanoma skin cancer) In 2005, more than 232.000 new cases were diagnosed in USA and more than 30.000 will die
More informationSupplementary Material. Part I: Sample Information. Part II: Pathway Information
Supplementary Material Part I: Sample Information Three NPC cell lines, CNE1, CNE2, and HK1 were treated with CYC202. Gene expression of 380 selected genes were collected at 0, 2, 4, 6, 12 and 24 hours
More informationHamburg Classification: Vascular Malformation
1 2 Hamburg Classification: Vascular Malformation 9 3 Dirk A. Loose and Raul E. Mattassi 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 AU1 Vascular malformations occur
More informationPI3K Background. The SignalRx R & D pipeline is shown below followed by a brief description of each program:
PI3K Background The phosphatidylinositol 3-kinase (PI3K) pathway is a key cell signaling node whose dysregulation commonly results in the transformation of normal cells into cancer cells. The role of PI3K
More informationAgro/Ansc/Bio/Gene/Hort 305 Fall, 2017 MEDICAL GENETICS AND CANCER Chpt 24, Genetics by Brooker (lecture outline) #17
Agro/Ansc/Bio/Gene/Hort 305 Fall, 2017 MEDICAL GENETICS AND CANCER Chpt 24, Genetics by Brooker (lecture outline) #17 INTRODUCTION - Our genes underlie every aspect of human health, both in function and
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Parkinson disease 8, automsomal dominant OMIM number for disease 607060 Disease
More informationCancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous
Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors
More information1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles:
Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Carcinogenesis Major Principles: 1. Nonlethal genetic damage is central to
More informationBases biológicas del cáncer de ovario en el siglo XXI
Bases biológicas del cáncer de ovario en el siglo XXI Iñigo Espinosa, M.D. Clínica Universidad de Navarra Epithelial Ovarian Tumors WHO 1973-2014 Serous Mucinous Endometrioid Clear cell Transitional Squamous
More informationDOI: /peds
Increased Expression of Urinary Matrix Metalloproteinases Parallels the Extent and Activity of Vascular Anomalies Jennifer J. Marler, Steven J. Fishman, Susan M. Kilroy, Jianmin Fang, Joseph Upton, John
More informationSirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study
Hammer et al. Orphanet Journal of Rare Diseases (2018) 13:191 https://doi.org/10.1186/s13023-018-0934-z RESEARCH Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations:
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationMUTATIONS, MUTAGENESIS, AND CARCINOGENESIS. (Start your clickers)
MUTATIONS, MUTAGENESIS, AND CARCINOGENESIS (Start your clickers) How do mutations arise? And how do they affect a cell and its organism? Mutations: heritable changes in genes Mutations occur in DNA But
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationChapt 15: Molecular Genetics of Cell Cycle and Cancer
Chapt 15: Molecular Genetics of Cell Cycle and Cancer Student Learning Outcomes: Describe the cell cycle: steps taken by a cell to duplicate itself = cell division; Interphase (G1, S and G2), Mitosis.
More informationAngiogenesis as a therapeutic target
Angiogenesis as a therapeutic target Lecture Experimentelle Krebsforschung SS 07 Prof. Gerhard Christofori Institute of Biochemistry and Genetics Department of Clinical-Biological Sciences University of
More informationGaucher disease 3/22/2009. Mendelian pedigree patterns. Autosomal-dominant inheritance
Mendelian pedigree patterns Autosomal-dominant inheritance Autosomal dominant Autosomal recessive X-linked dominant X-linked recessive Y-linked Examples of AD inheritance Autosomal-recessive inheritance
More informationThe molecular genetics of endometrial cancer
The molecular genetics of endometrial cancer Lora Hedrick Ellenson, M.D. Department of Pathology and Laboratory Medicine Weill Medical College of Cornell University Introduction Classification of endometrial
More informationIntroduction to Fetal Medicine: Genetics and Embryology
Introduction to Fetal Medicine: Genetics and Embryology Question: What do cancer biology, molecular biology, neurobiology, cell biology developmental biology and reproductive biology, all have in common?
More informationChapter 6. Villous Growth
Core Curriculum in Perinatal Pathology Chapter 6 Villous Growth Overview of vasculogenesis and angiogenesis Vasculogenesis Extraembryonic Vasculogenesis Angiogenesis Branching angiogenesis Sprouting angiogenesis
More informationWhat would you observe if you fused a G1 cell with a S cell? A. Mitotic and pulverized chromosomes. B. Mitotic and compact G1 chromosomes.
What would you observe if you fused a G1 cell with a S cell? A. Mitotic and pulverized chromosomes. B. Mitotic and compact G1 chromosomes. C. Mostly non-compact G1 chromosomes. D. Compact G1 and G2 chromosomes.
More informationVascular Malformations of the Brain: A Review of Imaging Features and Risks
Vascular Malformations of the Brain: A Review of Imaging Features and Risks Comprehensive Neuroradiology: Best Practices October 27-30, 2016 Sudhakar R. Satti, MD Associate Director Neurointerventional
More informationChromosomal Mutations
Notes 2/17 Chromosomal Mutations A chromosome mutation is an unpredictable change that occurs in a chromosome. These changes are most often brought on by problems that occur during meiosis or by mutagens
More informationMRC-Holland MLPA. Related SALSA MLPA probemixes P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, PTEN, TP53.
SALSA MLPA probemix P056-C1 TP53 Lot C1-0215 & lot C1-0214. As compared to version B1 (lot B1-1011) most of the reference and flanking probes have been replaced and several have been added. Furthermore,
More informationabstract ARTICLE BACKGROUND AND OBJECTIVE: Infantile hemangioma (IH) includes, among its other risk factors,
Inheritance Patterns of Infantile Hemangioma Eeva Castrén, MD, a Päivi Salminen, MD, b Miikka Vikkula, MD, PhD, c Anne Pitkäranta, MD, PhD, a Tuomas Klockars, MD, PhD a BACKGROUND AND OBJECTIVE: Infantile
More informationHemangiomas and Other Vascular Tumors
facebook.com/cincykidsrad Hemangiomas and Other Vascular Tumors Disclosures No relevant financial disclosures Bernadette L. Koch, M.D. Departments of Radiology and Pediatrics Cincinnati Children s Hospital
More informationComputational Systems Biology: Biology X
Bud Mishra Room 1002, 715 Broadway, Courant Institute, NYU, New York, USA L#4:(October-0-4-2010) Cancer and Signals 1 2 1 2 Evidence in Favor Somatic mutations, Aneuploidy, Copy-number changes and LOH
More informationTherapies for Overgrowth Disorders of PI3K-AKT Signalling Pathway. Dr Victoria E R Parker Cambridge University Hospitals NHS Trust
Therapies for Overgrowth Disorders of PI3K-AKT Signalling Pathway Dr Victoria E R Parker Cambridge University Hospitals NHS Trust Disclaimer A number of photographs included in Victoria s original presentation
More informationCrosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea
Crosstalk between Adiponectin and IGF-IR in breast cancer Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Obesity Chronic, multifactorial disorder Hypertrophy and hyperplasia
More informationAngiographic features of rapidly involuting congenital hemangioma (RICH)
Pediatr Radiol (2003) 33: 15 19 DOI 10.1007/s00247-002-0726-3 CASE REPORT Orhan Konez Patricia E. Burrows John B. Mulliken Steven J. Fishman Harry P.W. Kozakewich Angiographic features of rapidly involuting
More informationA class of genes that normally suppress cell proliferation. p53 and Rb..ect. suppressor gene products can release cells. hyperproliferation.
Tumor Suppressor Genes A class of genes that normally suppress cell proliferation. p53 and Rb..ect Mutations that inactivate the tumor suppressor gene products can release cells from growth suppression
More informationVessel malformation vascular malformation vascular malformation vascular malformation Vascular malformation vascular malformations
A vascular malformation is another type of birthmark, or congenital (present at birth) growth, made up of arteries, veins, capillaries, or lymphatic vessels. There are several different types of malformations
More informationDetermination Differentiation. determinated precursor specialized cell
Biology of Cancer -Developmental Biology: Determination and Differentiation -Cell Cycle Regulation -Tumor genes: Proto-Oncogenes, Tumor supressor genes -Tumor-Progression -Example for Tumor-Progression:
More information